Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Endourology
|
May 5, 2021
Stratification of Potency Outcomes Following Robot-Assisted Laparoscopic Radical Prostatectomy Based on Age, Preoperative Potency, and Nerve Sparing
Kulthe Ramesh Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma
Sean J Whittaker, Marie-France Demierre, Ellen J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Youn H Kim, Mahkam Tavallaee, Uma Sundram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications
Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the American Academy of Dermatology
|
October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management
Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Endourology
|
May 5, 2021
Stratification of Potency Outcomes Following Robot-Assisted Laparoscopic Radical Prostatectomy Based on Age, Preoperative Potency, and Nerve Sparing
Kulthe Ramesh Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma
Sean J Whittaker, Marie-France Demierre, Ellen J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Youn H Kim, Mahkam Tavallaee, Uma Sundram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications
Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the American Academy of Dermatology
|
October 12, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management
Tomoko Akaike, Manisha Thakuria, Ann W Silk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 7, 2022
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Page
of 5